PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Arthur Klausner to sit on the "VC Check-Up" panel at the "Life Sciences & Healthcare Venture Summit 2008" in New York City
News | 10. 30. 2008
